Viatris Inc
VTRSNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/303% below fair value
$19.63−0.25 (-1.26%)
Close on Nov 20, 2026Market cap $22.55BP/E –Yield 2.45%
Viatris Deferred Income Tax Liabilities, Net by Quarter
Deferred Income Tax Liabilities, Net ($M)
Viatris Deferred Income Tax Liabilities, Net: $776M in Q3 2026, down 24.5% from a year earlier. That is the lowest of the 25 quarters on record here.
Latest, Q3 2026
776
Period ended Sep 30, 2026
Change on a year earlier
-24.5%
1,028 in Q3 2025
History
25 quarters
Since Q4 2019
Sources
24
Documents cited below
Where the Q3 2026 figure comes from
Source: SEC Form 10-Q (2026-11-05) ↗
Reported in SEC Form 10-Q / 10-K Income Taxes Note.
quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Deferred Income Tax Liabilities, Net ($M) | Year on year | Source |
|---|---|---|---|---|
| Q3 2026 | Sep 30, 2026 | 776 | -24.5% | SEC Form 10-Q (2026-11-05) ↗ |
| Q2 2026 | Jun 30, 2026 | 803 | -25.7% | SEC Form 10-Q (2026-08-06) ↗ |
| Q1 2026 | Mar 31, 2026 | 871 | -19.6% | SEC Form 10-Q (2026-05-07) ↗ |
| Q4 2025 | Dec 31, 2025 | 892 | -19.5% | SEC Form 10-Q (2026-11-05) ↗ |
| Q3 2025 | Sep 30, 2025 | 1,028 | -19.5% | SEC Form 10-Q (2025-11-06) ↗ |
| Q2 2025 | Jun 30, 2025 | 1,081 | -31.3% | SEC Form 10-Q (2025-08-07) ↗ |
| Q1 2025 | Mar 31, 2025 | 1,083 | -35.3% | SEC Form 10-Q (2025-05-08) ↗ |
| Q4 2024 | Dec 31, 2024 | 1,108 | -36.2% | SEC Form 10-K (2026-02-26) ↗ |
| Q3 2024 | Sep 30, 2024 | 1,277 | -45.0% | SEC Form 10-Q (2024-11-07) ↗ |
| Q2 2024 | Jun 30, 2024 | 1,574 | -34.6% | SEC Form 10-Q (2024-08-08) ↗ |
| Q1 2024 | Mar 31, 2024 | 1,672 | -32.2% | SEC Form 10-Q (2024-05-09) ↗ |
| Q4 2023 | Dec 31, 2023 | 1,736 | -28.6% | SEC Form 10-K (2025-02-27) ↗ |
| Q3 2023 | Sep 30, 2023 | 2,319 | -6.8% | SEC Form 10-Q (2023-11-08) ↗ |
| Q2 2023 | Jun 30, 2023 | 2,408 | -8.0% | SEC Form 10-Q (2023-08-07) ↗ |
| Q1 2023 | Mar 31, 2023 | 2,465 | -9.7% | SEC Form 10-Q (2023-05-08) ↗ |
| Q4 2022 | Dec 31, 2022 | 2,432 | -13.6% | SEC Form 10-K (2024-02-28) ↗ |
| Q3 2022 | Sep 30, 2022 | 2,489 | -14.7% | SEC Form 10-Q (2022-11-07) ↗ |
| Q2 2022 | Jun 30, 2022 | 2,618 | -24.9% | SEC Form 10-Q (2022-08-08) ↗ |
| Q1 2022 | Mar 31, 2022 | 2,730 | -9.5% | SEC Form 10-Q (2022-05-09) ↗ |
| Q4 2021 | Dec 31, 2021 | 2,815 | -9.9% | SEC Form 10-K (2023-02-27) ↗ |
| Q3 2021 | Sep 30, 2021 | 2,918 | – | SEC Form 10-Q (2021-11-08) ↗ |
| Q2 2021 | Jun 30, 2021 | 3,486 | – | SEC Form 10-Q (2021-08-09) ↗ |
| Q1 2021 | Mar 31, 2021 | 3,015 | – | SEC Form 10-Q (2021-05-10) ↗ |
| Q4 2020 | Dec 31, 2020 | 3,124 | +91.9% | SEC Form 10-K (2022-02-28) ↗ |
| Q4 2019 | Dec 31, 2019 | 1,628 | – | SEC Form 10-K (2021-03-01) ↗ |
Cite this data
StockData. (2026). Viatris Deferred Income Tax Liabilities, Net ($M), quarterly Q4 2019–Q3 2026 [Data set]. Compiled from Viatris SEC filings and investor materials. https://stockdatahq.com/stocks/vtrs/kpis/dtl-net
See every metric in the Viatris KPI table. Data updated Nov 16, 2026.
See a number that looks wrong?